UBS AM’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-330,528
| Closed | -$6.66M | – | 2932 |
|
|
2021
Q3 | $6.66M | Sell |
330,528
-10,203
| -3% | -$206K | ﹤0.01% | 1246 |
|
|
2021
Q2 | $12.7M | Sell |
340,731
-1,809
| -0.5% | -$67.5K | 0.01% | 1038 |
|
|
2021
Q1 | $8.76M | Buy |
342,540
+6,558
| +2% | +$168K | ﹤0.01% | 1127 |
|
|
2020
Q4 | $7.4M | Sell |
335,982
-17,976
| -5% | -$396K | ﹤0.01% | 1154 |
|
|
2020
Q3 | $6.37M | Buy |
353,958
+2,822
| +0.8% | +$50.8K | ﹤0.01% | 1073 |
|
|
2020
Q2 | $8.92M | Buy |
351,136
+23,494
| +7% | +$597K | 0.01% | 935 |
|
|
2020
Q1 | $6.02M | Buy |
327,642
+269,359
| +462% | +$4.95M | ﹤0.01% | 994 |
|
|
2019
Q4 | $1.28M | Buy |
58,283
+8,372
| +17% | +$184K | ﹤0.01% | 1791 |
|
|
2019
Q3 | $717K | Buy |
49,911
+15,522
| +45% | +$223K | ﹤0.01% | 2112 |
|
|
2019
Q2 | $542K | Buy |
34,389
+18,287
| +114% | +$288K | ﹤0.01% | 2177 |
|
|
2019
Q1 | $236K | Hold |
16,102
| – | – | ﹤0.01% | 2403 |
|
|
2018
Q4 | $172K | Buy |
+16,102
| New | +$172K | ﹤0.01% | 2431 |
|